Ketamine-dependent neuronal activation in healthy volunteers

[1]  D. David,et al.  Ketamine treatment involves medial prefrontal cortex serotonin to induce a rapid antidepressant-like activity in BALB/cJ mice , 2017, Neuropharmacology.

[2]  E. Seifritz,et al.  Differential effects of rumination and distraction on ketamine induced modulation of resting state functional connectivity and reactivity of regions within the default-mode network. , 2016, Social cognitive and affective neuroscience.

[3]  S. Mitchell,et al.  The Rapidly Acting Antidepressant Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Rapidly Engage Dopaminergic Mood Circuits , 2016, The Journal of Pharmacology and Experimental Therapeutics.

[4]  H. Müller,et al.  Differential interaction with the serotonin system by S-ketamine, vortioxetine, and fluoxetine in a genetic rat model of depression , 2016, Psychopharmacology.

[5]  K. Hashimoto,et al.  Reduction of dopamine D2/3 receptor binding in the striatum after a single administration of esketamine, but not R-ketamine: a PET study in conscious monkeys , 2016, European Archives of Psychiatry and Clinical Neuroscience.

[6]  Jennifer Francois,et al.  Ketamine Suppresses the Ventral Striatal Response to Reward Anticipation: A Cross-Species Translational Neuroimaging Study , 2016, Neuropsychopharmacology.

[7]  E. Seifritz,et al.  Ketamine administration reduces amygdalo‐hippocampal reactivity to emotional stimulation , 2016, Human brain mapping.

[8]  Adam J. Schwarz,et al.  Modulatory effects of ketamine, risperidone and lamotrigine on resting brain perfusion in healthy human subjects , 2015, Psychopharmacology.

[9]  John H Krystal,et al.  Ketamine as a promising prototype for a new generation of rapid‐acting antidepressants , 2015, Annals of the New York Academy of Sciences.

[10]  Christian Windischberger,et al.  Ketamine-Induced Modulation of the Thalamo-Cortical Network in Healthy Volunteers As a Model for Schizophrenia , 2015, The international journal of neuropsychopharmacology.

[11]  Michael W. Cole,et al.  N-Methyl-D-Aspartate Receptor Antagonist Effects on Prefrontal Cortical Connectivity Better Model Early Than Chronic Schizophrenia , 2015, Biological Psychiatry.

[12]  Ram Adapa,et al.  Selective Augmentation of Striatal Functional Connectivity Following NMDA Receptor Antagonism: Implications for Psychosis , 2015, Neuropsychopharmacology.

[13]  M. Walter,et al.  Multistage drug effects of ketamine in the treatment of major depression , 2014, European Archives of Psychiatry and Clinical Neuroscience.

[14]  M Slifstein,et al.  Imaging glutamate in schizophrenia: review of findings and implications for drug discovery , 2014, Molecular Psychiatry.

[15]  Weina Zhang,et al.  The neural correlates of reward-related processing in major depressive disorder: a meta-analysis of functional magnetic resonance imaging studies. , 2013, Journal of affective disorders.

[16]  Dan V Iosifescu,et al.  Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. , 2013, The American journal of psychiatry.

[17]  Dennis S. Charney,et al.  Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression , 2013, Biological Psychiatry.

[18]  J. Krystal,et al.  Rapid-Acting Glutamatergic Antidepressants: The Path to Ketamine and Beyond , 2013, Biological Psychiatry.

[19]  S. Williams,et al.  Quantifying the Attenuation of the Ketamine Pharmacological Magnetic Resonance Imaging Response in Humans: A Validation Using Antipsychotic and Glutamatergic Agents , 2013, The Journal of Pharmacology and Experimental Therapeutics.

[20]  Andre F. Marquand,et al.  Test–retest reliability of the BOLD pharmacological MRI response to ketamine in healthy volunteers , 2013, NeuroImage.

[21]  G. McCarthy,et al.  Relationship of Resting Brain Hyperconnectivity and Schizophrenia-like Symptoms Produced by the NMDA receptor Antagonist Ketamine in Humans , 2012, Molecular Psychiatry.

[22]  P. Boesiger,et al.  Ketamine Decreases Resting State Functional Network Connectivity in Healthy Subjects: Implications for Antidepressant Drug Action , 2012, PloS one.

[23]  Bruce G. Jenkins,et al.  Pharmacologic magnetic resonance imaging (phMRI): Imaging drug action in the brain , 2012, NeuroImage.

[24]  I. Kanno,et al.  Anesthesia and the Quantitative Evaluation of Neurovascular Coupling , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[25]  Mark Slifstein,et al.  Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy. , 2012, Archives of general psychiatry.

[26]  P. Cowen,et al.  Lack of effect of ketamine on cortical glutamate and glutamine in healthy volunteers: a proton magnetic resonance spectroscopy study , 2012, Journal of psychopharmacology.

[27]  Nanxin Li,et al.  Signaling pathways underlying the rapid antidepressant actions of ketamine , 2012, Neuropharmacology.

[28]  G. Barker,et al.  Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology , 2012, Molecular Psychiatry.

[29]  P. Liddle,et al.  Does the salience network play a cardinal role in psychosis? An emerging hypothesis of insular dysfunction. , 2012, Journal of psychiatry & neuroscience : JPN.

[30]  Erno J. Hermans,et al.  Two-Week Administration of the Combined Serotonin-Noradrenaline Reuptake Inhibitor Duloxetine Augments Functioning of Mesolimbic Incentive Processing Circuits , 2011, Biological Psychiatry.

[31]  Tracy Warbrick,et al.  Ketamine effects on brain function — Simultaneous fMRI/EEG during a visual oddball task , 2011, NeuroImage.

[32]  Siegfried Kasper,et al.  Reduced resting-state functional connectivity between amygdala and orbitofrontal cortex in social anxiety disorder , 2011, NeuroImage.

[33]  Nanxin Li,et al.  Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure , 2011, Biological Psychiatry.

[34]  Clement Hamani,et al.  The Subcallosal Cingulate Gyrus in the Context of Major Depression , 2011, Biological Psychiatry.

[35]  Yuan Zhou,et al.  Functional segregation of the human cingulate cortex is confirmed by functional connectivity based neuroanatomical parcellation , 2011, NeuroImage.

[36]  Nanxin Li,et al.  mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists , 2010, Science.

[37]  Stefan A. Carp,et al.  The effect of different anesthetics on neurovascular coupling , 2010, NeuroImage.

[38]  J. Lauriello,et al.  1H-MRS at 4 Tesla in minimally treated early schizophrenia , 2010, Molecular Psychiatry.

[39]  P. Cowen,et al.  Diminished Neural Processing of Aversive and Rewarding Stimuli During Selective Serotonin Reuptake Inhibitor Treatment , 2010, Biological Psychiatry.

[40]  D. Charney,et al.  Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression , 2010, Biological Psychiatry.

[41]  Rupert Lanzenberger,et al.  Correlations and anticorrelations in resting-state functional connectivity MRI: A quantitative comparison of preprocessing strategies , 2009, NeuroImage.

[42]  K. Davis,et al.  Two systems of resting state connectivity between the insula and cingulate cortex , 2009, Human brain mapping.

[43]  A. Schleicher,et al.  Receptor architecture of human cingulate cortex: Evaluation of the four‐region neurobiological model , 2009, Human brain mapping.

[44]  N. Iacovidou,et al.  Pharmacological Aspects and Potential New Clinical Applications of Ketamine: Reevaluation of an Old Drug , 2009, Journal of clinical pharmacology.

[45]  Christophe Habas,et al.  Functional connectivity of the human rostral and caudal cingulate motor areas in the brain resting state at 3T , 2009, Neuroradiology.

[46]  Shane McKie,et al.  Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study. , 2008, Archives of general psychiatry.

[47]  Daniel S. Margulies,et al.  Mapping the functional connectivity of anterior cingulate cortex , 2007, NeuroImage.

[48]  F. Artigas,et al.  Clozapine and Haloperidol Differently Suppress the MK-801-Increased Glutamatergic and Serotonergic Transmission in the Medial Prefrontal Cortex of the Rat , 2007, Neuropsychopharmacology.

[49]  R. V. Van Heertum,et al.  Metabolite considerations in the in vivo quantification of serotonin transporters using 11C-DASB and PET in humans. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[50]  Paul J Carlson,et al.  A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. , 2006, Archives of general psychiatry.

[51]  David Borsook,et al.  A role for fMRI in optimizing CNS drug development , 2006, Nature Reviews Drug Discovery.

[52]  A. Lozano,et al.  Deep Brain Stimulation for Treatment-Resistant Depression , 2005, Neuron.

[53]  J. Lauriello,et al.  Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study. , 2005, The American journal of psychiatry.

[54]  M. Durieux,et al.  Ketamine for Perioperative Pain Management , 2005, Anesthesiology.

[55]  G. Reynolds,et al.  (3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients , 2005, Journal of Neural Transmission.

[56]  D. Lorrain,et al.  Effects of ketamine and n-methyl-d-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268 , 2003, Neuroscience.

[57]  Ravi S. Menon,et al.  Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers. , 2002, The American journal of psychiatry.

[58]  Richard G. Wise,et al.  Combining fMRI with a Pharmacokinetic Model to Determine Which Brain Areas Activated by Painful Stimulation Are Specifically Modulated by Remifentanil , 2002, NeuroImage.

[59]  K. Davis,et al.  Implications for altered glutamate and GABA metabolism in the dorsolateral prefrontal cortex of aged schizophrenic patients. , 2002, The American journal of psychiatry.

[60]  H. Sackeim,et al.  Decreased regional brain metabolism after ect. , 2001, The American journal of psychiatry.

[61]  John H Krystal,et al.  Antidepressant effects of ketamine in depressed patients , 2000, Biological Psychiatry.

[62]  D Hell,et al.  Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans. , 2000, Journal of psychiatric research.

[63]  A Kriss,et al.  Comparison of the effects of four anaesthetic agents on somatosensory evoked potentials in the rat , 1999, Laboratory animals.

[64]  M. Raichle,et al.  Subgenual prefrontal cortex abnormalities in mood disorders , 1997, Nature.

[65]  G. Geisslinger,et al.  Pharmacokinetics and pharmacodynamics of ketamine enantiomers in surgical patients using a stereoselective analytical method. , 1993, British Journal of Anaesthesia.